Cyanotic infants experience coagulation disorders
Clinical studies consistently show that cyanotic infants and children with congenital heart disease experience various coagulation disorders, including thrombocytopenia, prolonged prothrombin times, and clotting factor deficiencies.
Multiple papers (specifically [2] and [6]) investigate and confirm hemostatic complications and coagulation disorders in cyanotic infants and children with congenital heart disease. The retrieved literature clearly supports the claim.
Papadogeorgou P, Valsami S, Boutsikou M, Pergantou E, Mantzou A, Papassotiriou I, Iliodromiti Z, Sokou R, Bouza E, Politou M, Iacovidou N, Boutsikou T. Coagulation Profile in Neonates with Congenital Heart Disease: A Pilot Study.. 2024. https://doi.org/10.3390/medicina60020268
Demonstrates that cyanotic congenital heart disease in neonates is accompanied by coagulation abnormalities and impaired hemostatic profiles.
See more details
Saqlain N, Kazmi T, Ghous M, Sadiq M. Bleeding and Thrombotic Challenges in Children with uncorrected Cyanotic Congenital Heart Diseases (CCHD)- Experience from a tertiary care pediatric hospital.. 2025. https://doi.org/10.12669/pjms.41.11.12609
Highlights significant coagulation challenges in children with uncorrected cyanotic congenital heart disease, including thrombocytopenia and clotting factor deficiencies.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt